🇺🇸 FDA
Patent

US 12285435

Multivesicular liposome formulations of dexamethasone

granted A61KA61K31/573A61K9/127

Quick answer

US patent 12285435 (Multivesicular liposome formulations of dexamethasone) held by Pacira Pharmaceuticals, Inc. expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Pacira Pharmaceuticals, Inc.
Grant date
Tue Apr 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/573, A61K9/127, A61K9/1277